• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 1999

View Archived Issues

Gene that causes familial British dementia discovered

Read More

Onyvax and Erasmus University reach prostate cancer agreement

Read More

Cambridge Combinatorial to provide chemistry services to Pfizer

Read More

Pharming begins phase I development of human lactoferrin

Read More

FDA grants orphan drug designation for Ceresine in traumatic brain injury

Read More

CollaGenex signs marketing agreement for Periostat in Canada

Read More

Cerus initiates phase I allogeneic bone marrow transplant study

Read More

Amylin initiates phase II study of AC-2993 in type II diabetes

Read More

Novo Nordisk seeks approval for liquid GH in the U.S.

Read More

GW-420867X is a promising component of anti-HIV combination therapy

Read More

DAPD: another promising agent for combination therapy of HIV/AIDS

Read More

Howard Hughes researchers uncover mechanism of interferon resistance in HCV

Read More

Neuroprotectants in early development at Pharmacia & Upjohn

Read More

Thienopyrimidine inhibitors of PDE5 described by Merck KGaA

Read More

P&U studies compounds that intervene in the kynurenine metabolic pathway

Read More

Epimmune-Cytel merger complete; new company up and running

Read More

Astra (AstraZeneca) presents new agents for GI inflammatory disorders

Read More

Alsterpaullone is a potent CDK1/cyclin B inhibitor and antitumor agent

Read More

New compounds from Senju under evaluation for complications of diabetes

Read More

Antifungal triazoles patented by SS Pharm.

Read More

Fujisawa prepares new cephem antibiotics

Read More

Russian scientists test GVS-111 in preclinical assays

Read More

Renal allograft survival is prolonged by treatment with anti-CD4-idarubicin immunoconjugate

Read More

NCC-1048 is a novel neuronal calcium channel blocker with potential in cerebral ischemia

Read More

Stable HLE inhibitors with in vivo activity in lung hemorrhage model identified at Chinoin

Read More

Novel noncompetitive AMPA antagonist presented at European Congress of Pharmacology

Read More

Kissei seeks approval of amprenavir in Japan

Read More

Noncompetitive AMPA receptor antagonist emerges as development candidate for stroke, epilepsy, etc.

Read More

Second-generation PDE4 inhibitors highlighted at World Congress on Inflammation

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe